Differing HOAs in cataract patients

Article

Different types of early lenticular opacities in cataract patients induce different wavefront aberration profiles, according to a study published in the August issue of the Journal of Cataract and Refractive Surgery.

Different types of early lenticular opacities in cataract patients induce different wavefront aberration profiles, according to a study published in the August issue of the Journal of Cataract and Refractive Surgery.

Karolinne Maia Rocha and colleagues from the Federal University of Sao Paulo, Brazil, looked at 105 eyes of 65 patients with bilateral cataract, classified according to the Lens Opacities Classification System III (LOCS III). All eyes underwent a complete ophthalmic examination, including corneal topography and wavefront analysis. Higher order aberrations were compared between the nuclear, cortical and posterior subcapsular groups for statistical significance.

The researchers found that 28 eyes (23.3%) had predominantly nuclear opacification and 13 (10.83%) had mainly cortical opacification. Sixty-four eyes had a mixed pattern of LOCS III classification, which hindered the establishment of a correlation between the aberrometry and cataract type.

In eyes with nuclear opacification, the mean spherical aberration with a 6 mm pupil was 0.45±0.17 µm and the mean coma was 0.29±0.13 µm. In eyes with predominantly cortical cataract, mean spherical aberration was 0.12±0.10 µm and the mean coma was 0.49±0.23 µm. The cortical cataract group had significantly higher coma than any other group (p<0.001) and the nuclear cataract group had significantly higher spherical aberrations than the other groups (p<0.001).

It was concluded that different types of early lenticular opacities induce different wavefront aberration profiles.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.